Spruce Biosciences, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
SPRB on OTC
Location
611 Gateway Boulevard, Suite 740, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10/7/2024

Spruce Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novo Holdings A/S 10%+ Owner $1.92M Mar 21, 2024
Niall O'Donnell Director $1.3M May 25, 2023
Javier B. Szwarcberg CHIEF EXECUTIVE OFFICER, Director $349K Dec 10, 2024
Samir Gharib President And Cfo $165K Dec 10, 2024
Ralph William Charlton III Chief Medical Officer $87.4K Dec 10, 2024
Subaweerage Dias Chief Medical Officer $33.2K Dec 16, 2021
Richard King Chief Executive Officer, Director $2.18K Jun 30, 2021
Michael G. Grey Executive Chairman, Director Jul 22, 2025
Percival Barretto-Ko Director Jul 22, 2025
Bali Muralidhar Director Jul 22, 2025
Tiba Aynechi Director Jul 22, 2025
Camilla V. Simpson Director Jul 22, 2025
Dina Chaya Director May 25, 2022
Kirk Ways Interim Chief Medical Officer, Director Jul 23, 2025
Daniel K. Spiegelman Director Jul 22, 2025

Recent Insider Transactions by Companies or Individuals for Spruce Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.